Industry News
Cytopia begins Phase II
Cytopia in Phase II trials of its vascular disrupting agent CYT997 in brain cancer [ + ]
Anadis to commercialise BioGard
BioGard is a supplemented bovine colostrum powder for immune system health [ + ]
Scheme to attract world-leading researchers
The federal government has allocated $239 million over five years to a a new Australian Laureate Fellowships scheme. Up to 15 Laureate Fellowships will be awarded every year. Each fellowship will be worth around $3 million over five years and will allow the Fellow to work with, and mentor, up to four postdoctoral and postgraduate researchers.
[ + ]Geologist to head CSIRO
Megan Clark named as new head of CSIRO [ + ]
Anadis clinical trial gets go-ahead
Anadis obtains Israeli govt approval for mucositis trial protocol [ + ]
New head for CSIRO
Dr Megan Clark will commence as the chief executive of CSIRO in January 2009 after Dr Geoff Garrett's term ends on 31 December this year.
[ + ]Free access to Elaprase
Government to fund Genzyme's Elaprase for Hunter syndrome patients [ + ]
Electronic underpants revealed
The SimPAD wetness monitoring devices to feature on New Inventors [ + ]
Dengue vaccine study
Hawaii Biotech's dengue vaccine program to be supported by Walter Reed [ + ]
Women in Science Fellowship winner
A L’Oreal Australia For Women in Science Fellowship has been awarded to WEHI immunologist Dr Erika Cretney. The fellowship is designed to assist women to consolidate their careers and rise to leadership positions and can be used to defray childcare costs in addition to research costs.
[ + ]Modified viruses bring malaria vaccine hope
An international collaboration of researchers has created a promising malaria vaccine based on pox and cold viruses.
[ + ]Progen gets strategic advice
Independent advisory firm to help Progen with planning following termination of PI88 study. [ + ]
NeuroDiscovery has teeth
NeuroDiscovery demonstrates effectiveness of NSL-101 in dental surgery [ + ]
Generic partners India pharma
Indian pharma Lupin invests in Generic Health [ + ]
Biota records small year-end loss
Biota’s long-running legal battle with GSK has taken its toll, with the company recording a $20 million loss for the year. [ + ]